Jun. 20, 2016 / PRZen / SAN DIEGO — SpineOvations, Inc., a California-based medical device company developing novel minimally invasive therapies for spinal disc diseases, announced the appointment of Bill Nydam, M.B.A., CPA, to its board of directors, effective immediately. Bill will serve as an independent director and member of the audit committee.
“Bill brings a wealth of health care experience to SpineOvations and will play a key role as SpineOvations continues its vision of developing novel minimally invasive therapies for patients suffering from lower back pain,” said Niv Caviar, SpineOvations CEO. “Bill’s expertise and proven track record in the medical device and life science space will be a tremendous asset to SpineOvations.”
Bill Nydam is currently President and CEO of CryoMedix. He has over 30 years of leadership experience in healthcare. He has started several companies, turned around several companies, was the President of Endocare, a publically traded cryoablation company, and managed a venture capital fund. He has created several billions of dollars of shareholder value in his career to date. Bill received his B.S. in Accounting and Master of Business Administration at the University of California at Berkeley.
“I am honored to be selected to sit on SpineOvation’s board,” said Bill Nydam. “I’ve been impressed with the great potential of the DiscSeal platform technology, preliminary in vitro and in vivo efficacy and safety results in addition to the experience of the board and management. DiscSeal has the potential to be the first minimally invasive solution for those patients who fail first line therapy for lower back pain and desire an alternative to surgery.”
The Company’s current board of directors are Neville Alleyne, MD; Bill Taylor, MD; Stuart Young, MD; and Niv Caviar.
DiscSeal, delivered via a simple percutaneous injection, is a patented, proprietary formulation of biocompatible synthetic microspheres and a viscous carrier specifically designed for disc augmentation, thereby minimizing progression of internal disc disruption and disc degeneration disease, one of the most common causes of lower back pain. Initial results show that DiscSeal is safe and remains in the injected disc without extrusion, and the discs maintained their disc height.
SpineOvations (SO) is a mid-stage medical device company focused on developing innovative minimally invasive therapies for the intervertebral disc and lower back pain conditions. SO’s DiscSeal technology is patented. The company is founded by well-known spinal and neurosurgeons and led by experienced executives in the life sciences. For further information, visit the company’s website at www.spineovations.com.
Niv Caviar, Chief Executive Officer
Press release distributed by PRZen